Derma Sciences Inc (DSCI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
214 CARNEGIE CENTER, SUITE 300 PRINCETON, NJ 08540 |
| State of Incorp. | PA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2016 MRQ | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments, including: | 56,928 | 75,393 | 21,980 | 45,845 | |||
| Cash and cash equivalents | 15,814 | 19,397 | 6,502 | 41,617 | |||
| Short-term investments | 25,004 | 55,996 | 15,478 | 3,730 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 16,110 | 498 | |||||
| Receivables | 8,146 | 8,758 | 7,333 | 7,086 | |||
| Inventory, net of allowances, customer advances and progress billings | 20,691 | 13,281 | 16,473 | 13,671 | |||
| Inventory | 20,691 | 13,281 | 16,473 | 13,671 | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 3,209 | ||
| Deferred tax assets | 7 | 28 | |||||
| Other undisclosed current assets | (14,661) | 3,404 | 3,718 | (498) | |||
| Total current assets: | 71,104 | 100,844 | 49,532 | 69,312 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 4,129 | 3,614 | 2,953 | 3,305 | |||
| Long-term investments and receivables | 16,110 | 8,423 | 7,858 | 498 | |||
| Long-term investments | 16,110 | 8,423 | 7,858 | 498 | |||
| Intangible assets, net (including goodwill) | 23,289 | 26,273 | 28,094 | 30,587 | |||
| Goodwill | 13,458 | 13,458 | 13,458 | 13,458 | |||
| Intangible assets, net (excluding goodwill) | 9,831 | 12,816 | 14,636 | 17,129 | |||
| Other noncurrent assets | 148 | 144 | 139 | ✕ | |||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | 141 | ||
| Total noncurrent assets: | 43,676 | 38,454 | 39,045 | 34,531 | |||
| TOTAL ASSETS: | 114,780 | 139,298 | 88,576 | 103,843 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 11,555 | 8,453 | 7,052 | 5,923 | |||
| Employee-related liabilities | 2,391 | 2,931 | 2,529 | 1,930 | |||
| Accounts payable | 2,473 | 5,059 | 4,523 | 3,994 | |||
| Accrued liabilities | 6,691 | 464 | |||||
| Restructuring reserve | 1,492 | ✕ | ✕ | ||||
| Other liabilities | 1,867 | 1,279 | 823 | ||||
| Deferred tax liabilities | 1,701 | 1,694 | |||||
| Other undisclosed current liabilities | 488 | (510) | (534) | 1,380 | |||
| Total current liabilities: | 13,535 | 11,511 | 9,492 | 8,127 | |||
| Noncurrent Liabilities | |||||||
| Liabilities, other than long-term debt | 2,819 | 2,743 | 2,179 | 2,273 | |||
| Deferred revenue and credits | 521 | 242 | 269 | ||||
| Deferred tax liabilities, net | 1,805 | 1,701 | 1,694 | 1,736 | |||
| Other liabilities | 1,014 | 521 | 242 | 269 | |||
| Other undisclosed noncurrent liabilities | (521) | (242) | (269) | ||||
| Total noncurrent liabilities: | 2,819 | 2,222 | 1,936 | 2,005 | |||
| Total liabilities: | 16,354 | 13,733 | 11,428 | 10,131 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 98,426 | 125,565 | 77,148 | 93,711 | |||
| Preferred stock | 1 | 1 | 1 | 1 | |||
| Common stock | 259 | 253 | 173 | 165 | |||
| Additional paid in capital | 234,943 | 228,342 | 140,065 | 132,163 | |||
| Accumulated other comprehensive income | 5,273 | 972 | 1,218 | 1,589 | |||
| Accumulated deficit | (142,050) | (103,942) | (64,171) | (40,207) | |||
| Other undisclosed equity, attributable to parent | (61) | (138) | |||||
| Total equity: | 98,426 | 125,565 | 77,148 | 93,711 | |||
| TOTAL LIABILITIES AND EQUITY: | 114,780 | 139,298 | 88,576 | 103,843 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 84,474 | 83,746 | 79,711 | 72,648 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (51,740) | (53,636) | (50,328) | (49,807) | ||
| Other undisclosed gross profit | 7 | 2,300 | ||||
| Gross profit: | 32,734 | 30,110 | 29,390 | 25,141 | ||
| Operating expenses | (54,696) | (70,214) | (53,380) | (39,608) | ||
| Operating loss: | (21,962) | (40,104) | (23,990) | (14,468) | ||
| Nonoperating income (expense) | (650) | 182 | 186 | 27 | ||
| Investment income, nonoperating | 289 | 226 | 75 | |||
| Gain (loss), foreign currency transaction, before tax | 280 | (408) | ||||
| Other nonoperating income | 6 | |||||
| Loss from continuing operations before income taxes: | (22,611) | (39,923) | (23,804) | (14,441) | ||
| Income tax expense (benefit) | 2,245 | 151 | (160) | 2,370 | ||
| Loss from continuing operations: | (20,367) | (39,772) | (23,964) | (12,070) | ||
| Loss before gain (loss) on sale of properties: | (20,367) | (39,772) | (23,964) | (12,070) | ||
| Net loss: | (20,367) | (39,772) | (23,964) | (12,070) | ||
| Net loss attributable to noncontrolling interest | (17,741) | |||||
| Net loss available to common stockholders, diluted: | (38,107) | (39,772) | (23,964) | (12,070) | ||
Comprehensive Income ($ in thousands)
| 9/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Net loss: | (20,367) | (39,772) | (23,964) | (12,070) | ||
| Other comprehensive income (loss) | 4,361 | (169) | (509) | |||
| Comprehensive loss: | (16,005) | (39,940) | (24,473) | (12,070) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (17,741) | |||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 86 | |||||
| Comprehensive loss, net of tax, attributable to parent: | (33,746) | (39,940) | (24,473) | (11,984) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.